Clinical Trial Update: Oral N-acetylcysteine for Retinitis Pigmentosa [Phase 3]

View source ↗

Summary

Phase 3 trial of oral N-acetylcysteine for Retinitis Pigmentosa is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Retinitis Pigmentosa | Phase 3 | Status: ACTIVE_NOT_RECRUITING